These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6339439

  • 21. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU, Wissler JH, Damerau B.
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Enhancement of the chemotactic response of bovine polymorphonuclear leukocytes by levamisole.
    Jayappa HG, Loken KI.
    Am J Vet Res; 1982 Dec; 43(12):2138-42. PubMed ID: 6762119
    [Abstract] [Full Text] [Related]

  • 25. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils.
    Bae YS, Park JC, He R, Ye RD, Kwak JY, Suh PG, Ho Ryu S.
    Mol Pharmacol; 2003 Sep; 64(3):721-30. PubMed ID: 12920210
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL, Karlsson J, Wennerås C, Bylund J, Fu H, Dahlgren C.
    Biochem Pharmacol; 2007 Oct 01; 74(7):1050-6. PubMed ID: 17692291
    [Abstract] [Full Text] [Related]

  • 31. Chemotactic receptor of cord blood granulocytes to the synthesized chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Nunoi H, Endo F, Chikazawa S, Namikawa T, Matsuda I.
    Pediatr Res; 1983 Jan 01; 17(1):57-60. PubMed ID: 6300743
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS, Jenkins MK, Nelson RD, Chenoweth D, Simmons RL.
    Surgery; 1981 Aug 01; 90(2):319-27. PubMed ID: 7256544
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Interaction of human neutrophils and HL-60 cells with the extracellular matrix.
    Suchard SJ.
    Blood Cells; 1993 Aug 01; 19(2):197-221, discussion 221-3. PubMed ID: 7508769
    [Abstract] [Full Text] [Related]

  • 37. Effects of alpha 1-proteinase inhibitor on chemotaxis and chemokinesis of polymorphonuclear leukocytes: its possible role in regulating polymorphonuclear leukocyte recruitment in human subjects.
    Aoshiba K, Nagai A, Ishihara Y, Kagawa J, Takizawa T.
    J Lab Clin Med; 1993 Sep 01; 122(3):333-40. PubMed ID: 8409709
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of chemotaxis of neutrophil leukocytes to interleukin-8 by endotoxins of various bacteria.
    Bignold LP, Rogers SD, Siaw TM, Bahnisch J.
    Infect Immun; 1991 Nov 01; 59(11):4255-8. PubMed ID: 1937782
    [Abstract] [Full Text] [Related]

  • 39. Chemoattractant receptors of neonatal polymorphonuclear leukocytes: lack of modulation of the receptors by membrane modifier.
    Yasui K.
    Acta Paediatr Jpn; 1989 Apr 01; 31(2):150-7. PubMed ID: 2560607
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.